• Donate
  • I want to learn
    • Overview
    • Frequently Asked Questions
    • Progressive Supranuclear Palsy
    • Corticobasal Degeneration
    • Multiple System Atrophy
    • Research
    • Healthcare Professional Resources
    • The FTD Disorders Registry
    • CurePSPTV
  • I need Support
    • Overview
    • Centers of Care
    • Educational Resources
    • Support Group
    • Bereavement Resources
    • Request Information
    • Respite Grant
    • Personal Stories
    • Brain Donation
    • Forums
  • I want to help
    • Overview
    • Ways to Give
    • Volunteer
    • Fundraising
    • Recognition Wall
    • Merchandise Store
    • Genetics Consortium
  • About CurePSP
    • Overview
    • News
    • Calendar
    • Our Team
    • Board of Directors
    • Our Partners
    • Annual Reports and Policies
    • Scientific Advisory Board
 

1216 Broadway
2nd Floor
New York, NY 10001

Hope Line: 800-457-4777
Fax: 410-785-7009
info@curepsp.org

MENU
  • Donate
  • I Want to Learn
  • I Need Support
  • I Want to Help

Newly Funded Research Grants 2022

Dr. Edwin Jabbari, Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology, London, UK - New Pipeline Grant

Dr. Edwin Jabbari, Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology, London, UK - New Pipeline Grant

Fluid markers of LRRK2 as a determinant of PSP risk and disease progression

Click Here to Read Edwin Jabbari's Full Study
Dr. Shu Chen, Pathology, University of Alabama, Birmingham, AL - New Pipeline Grant

Dr. Shu Chen, Pathology, University of Alabama, Birmingham, AL - New Pipeline Grant

Development of RT-QuIC Assays of Skin Biopsy for Early Diagnosis of PSP

Click Here to Read Shu Chen's Full Study
Dr. Johannes Levin, Department of Neurology, LMU Hospital, Munich, Germany - New Pathway Grant

Dr. Johannes Levin, Department of Neurology, LMU Hospital, Munich, Germany - New Pathway Grant

In vivo assessment of reactive astrogliosis in PSP

Click Here to Read Johannes Levin's Full Study
Dr. Naomi Visanji, Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada - New Pathway Grant

Dr. Naomi Visanji, Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada - New Pathway Grant

Prioritizing the in vivo modeling of Progressive Supranuclear Palsy

Click Here to Read Naomi Visanji's Full Study
Dr. Sarah Hopp, Glenn Biggs Institute for Neurodegenerative Disorders, The University of Texas Health Science Center, San Antonio, TX

Dr. Sarah Hopp, Glenn Biggs Institute for Neurodegenerative Disorders, The University of Texas Health Science Center, San Antonio, TX

Harnessing Microglia to Internalize and Degrade Tau

Click Here to Read Sarah Hopp's Full Study
Dr. Mikael Simons, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany

Dr. Mikael Simons, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany

Evaluation of Fluid-Based and Imaging Biomarkers for Interventional Trials in PSP

Click Here to Read Mikael Simons' Full Study
Dr. Hong Xu, Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

Dr. Hong Xu, Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

Understanding the Diversity of Tau Pathogenesis in PSP

Click Here to Read Hong Xu Full Study

Ongoing Funded Grants

Dr. Marta Olah, Department of Neurology, Columbia University, New York, NY

Dr. Marta Olah, Department of Neurology, Columbia University, New York, NY

Identification of Microglia Phenotypes Associated with Tau Pathology in PSP and CBD

Click Here to Read Marta Olah’s Full Study
Dr. Maria Catarina Lima da Silva, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Dr. Maria Catarina Lima da Silva, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Investigation of ULK1-Based Autophagy Activators as Therapeutics for Tauopathies

Click Here to Read Maria Catarina Lima da Silva’s Full Study
Dr. Daniel H. Geschwind, Department of Neurology, UCLA, Los Angeles, CA

Dr. Daniel H. Geschwind, Department of Neurology, UCLA, Los Angeles, CA

Aminopeptidase Enhancers as Novel PSP Pharmacotherapies

Click Here to Read Daniel Geschwind’s Full Study
Dr. Rachel Baily, Center for Alzheimer's and Neurodegenerative Diseases, UT Southwestern Medical Center, Dallas, TX

Dr. Rachel Baily, Center for Alzheimer's and Neurodegenerative Diseases, UT Southwestern Medical Center, Dallas, TX

Gene Replacement Therapy for Tauopathies

Click Here to Read Rachel Baily’s Full Study
Dr. Franziska Hopfner, Department of Neurology, Hannover Medical School, Hannover, Germany

Dr. Franziska Hopfner, Department of Neurology, Hannover Medical School, Hannover, Germany

MicroRNA profile of isolated brain cell populations in PSP

Click Here to Read Franziska Hopfner’s Full Study
Dr. Chao Peng, Department of Neurology, UCLA David Geffen School of Medicine, Los Angeles, California

Dr. Chao Peng, Department of Neurology, UCLA David Geffen School of Medicine, Los Angeles, California

The Role of Post-Translational Modifications on Tau Transmission in PSP

Click Here to Read Chao Peng’s Full Study
Dr. Rohan de Silva, UCL Queen Square Institute of Neurology, London, UK

Dr. Rohan de Silva, UCL Queen Square Institute of Neurology, London, UK

Do distinct 4R-tau seeding strains cause disease heterogeneity in PSP and CBD?

Click Here to Read Rohan de Silva’s Full Study
Dr. Rik van der Kant, Functional Genomics Department, Vrije Universiteit Amsterdam, Amsterdam, Holland

Dr. Rik van der Kant, Functional Genomics Department, Vrije Universiteit Amsterdam, Amsterdam, Holland

Low-dose efavirenz as a disease-modifying intervention for primary Tauopathies

Click Here to Read Rik van der Kant’s Full Study
Dr. Rueben Das, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

Dr. Rueben Das, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

Connecting GWAS signal in TAU Locus to Effector Variant in Tauopathies

Click Here to Read Rueben Das’ Full Study
Dr. Amanda L. Woerman, University of Massachusetts, Amherst, MA

Dr. Amanda L. Woerman, University of Massachusetts, Amherst, MA

Investigating PSP and CBD Tau Strain Biology to Support Novel Diagnostic Development

Click Here to Read Amanda Woerman’s Full Study
Dr. John M. Ringman, Keck School of Medicine at the University of Southern California, Los Angeles, CA

Dr. John M. Ringman, Keck School of Medicine at the University of Southern California, Los Angeles, CA

Genotyping Familial Progressive Supranuclear Palsy

Click Here to Read John Ringman’s Full Study
Dr. David C. Butler, Neural Stem Cell Institute, Regenerative Research Foundation, Rensselaer, NY

Dr. David C. Butler, Neural Stem Cell Institute, Regenerative Research Foundation, Rensselaer, NY

Bifunctional Intrabodies to Lower Tau

Click Here to Read David C. Butler's Full Study
Dr. Gal Bitan, University of California, Los Angeles

Dr. Gal Bitan, University of California, Los Angeles

Biomarkers In Brain-Derived Blood Exosomes For Improved PSP Diagnosis

Click Here to Read Gal Bitan's Full Study
Dr. Maria-Elena Avale, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular, Buenos Aires, Argentina

Dr. Maria-Elena Avale, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular, Buenos Aires, Argentina

Dissecting Neuronal Dysfunctions Under 3R:4R Tau Isoforms Imbalance 

Click Here to Read Maria-Elena Avale's Full Study
Back to Research Back to Top

1216 Broadway
2nd Floor
New York, NY 10001

Hope Line: 800-457-4777
Fax: 410-785-7009
info@curepsp.org

©2022 CurePSP, Inc., unless attribution otherwise noted.
CurePSP, Unlocking the Secrets of Brain Disease, and Because Hope Matters are registered trademarks of CurePSP, Inc.

Security and Privacy Policy

To translate this site, click here.

 

Join Our Mailing List

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT